Richard Kinh Gian

Active 1996–2025

102
Papers
19,150
Citations
52
h-index
90
i10-index

Citations

Citations per year for Richard Kinh Gian1951: 1 citations1969: 1 citations1981: 1 citations1992: 1 citations1993: 1 citations1995: 1 citations1996: 1 citations1997: 1 citations1998: 3 citations1999: 1 citations2000: 2 citations2001: 15 citations2002: 30 citations2003: 58 citations2004: 71 citations2005: 39 citations2006: 50 citations2007: 46 citations2008: 37 citations2009: 39 citations2010: 37 citations2011: 37 citations2012: 34 citations2013: 38 citations2014: 44 citations2015: 41 citations2016: 54 citations2017: 66 citations2018: 94 citations2019: 539 citations2020: 837 citations2021: 1,024 citations2022: 989 citations2023: 1,017 citations2024: 1,577 citations2025: 1,047 citations2026: 159 citations2027: 1 citations1952–1968: no citations, so these years are not shown1970–1980: no citations, so these years are not shown1982–1991: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,384 citing papers, 21% of this breakdownChina: 1,647 citing papers, 14.5% of this breakdownUnited Kingdom: 566 citing papers, 5% of this breakdownItaly: 542 citing papers, 4.8% of this breakdownGermany: 540 citing papers, 4.7% of this breakdownIndia: 476 citing papers, 4.2% of this breakdownSouth Korea: 409 citing papers, 3.6% of this breakdownFrance: 380 citing papers, 3.3% of this breakdownCanada: 359 citing papers, 3.1% of this breakdownJapan: 330 citing papers, 2.9% of this breakdownAustralia: 257 citing papers, 2.3% of this breakdownSpain: 254 citing papers, 2.2% of this breakdown
0%21%Other 28.4%

Fields

  • Medicine52.2%
  • Computer Science16.9%
  • Biochemistry, Genetics and Molecular Biology11.7%
  • Engineering5.1%
  • Immunology and Microbiology4%
  • Neuroscience2.9%
  • Other7.2%

Topics

  • Radiomics and Machine Learning in Medical Imaging6.2%
  • Hepatocellular Carcinoma Treatment and Prognosis5.4%
  • AI in cancer detection3.4%
  • Pancreatic and Hepatic Oncology Research3.3%
  • Advanced Neural Network Applications2.7%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.2%
  • Other76.8%

Coauthors

All papers

Open in search
  1. Convolutional neural networks: an overview and application in radiology

    Authors: , , , - Insights into Imaging 2018 cited by 4,597

  2. The Medical Segmentation Decathlon

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sihong Chen, Laura Daza, Jianjiang Feng, Baochun He, Fabian Isensee, Yuanfeng Ji, Fucang Jia, Ildoo Kim, Klaus Maier‐Hein, Dorit Merhof, Akshay Pai, Beomhee Park, Mathias Perslev, R. Rezaiifar, Oliver Rippel, Ignacio Sarasúa, Wei Shen, Jaemin Son, Christian Wachinger, Liansheng Wang, Yan Wang, Yingda Xia, Daguang Xu, Zhanwei Xu, Yefeng Zheng, Amber L. Simpson, Lena Maier‐Hein, M. Jorge Cardoso - Nature Communications 2022 cited by 1,202

  3. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Kinh Gian, Andrew S. Epstein, Parisa Momtaz, Wungki Park, Ryan Sugarman, Anna M. Varghese, Elizabeth Won, Avni M. Desai, Alice C. Wei, Michael I. D’Angelica, T. Peter Kingham, Ira Mellman, Taha Merghoub, Jedd D. Wolchok, Uğur Şahin, Özlem Türeci, Benjamin D. Greenbaum, William R. Jarnagin, Jeffrey A. Drebin, Eileen M. O’Reilly, Vinod P. Balachandran - Nature 2023 cited by 1,350

  4. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients

    Authors: , , , , , , , , , , , - Radiology 2018 cited by 1,115

  5. Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 592

  6. Modeling of loops in protein structures

    Authors: , , - Protein Science 2000 cited by 2,177

  7. Artificial Intelligence in CT and MR Imaging for Oncological Applications

    Authors: , , , , , , , , , , , , - Cancers 2023 cited by 103

  8. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William R. Jarnagin - JAMA Oncology 2019 cited by 223

  9. The Medical Segmentation Decathlon

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Byeonguk Bae, Sihong Chen, Laura Daza, Jianjiang Feng, Baochun He, Fabian Isensee, Yuanfeng Ji, Fucang Jia, Namkug Kim, Ildoo Kim, Dorit Merhof, Akshay Pai, Beomhee Park, Mathias Perslev, R. Rezaiifar, Oliver Rippel, Ignacio Sarasúa, Wei Shen, Jaemin Son, Christian Wachinger, Liansheng Wang, Yan Wang, Yingda Xia, Daguang Xu, Zhanwei Xu, Yefeng Zheng, Amber L. Simpson, Lena Maier‐Hein, M. Jorge Cardoso - arXiv (Cornell University), CoRR 2021 cited by 101

  10. Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 398

  11. Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eytan M. Stein, Andrew M. Intlekofer - Cancer Discovery 2018 cited by 212

  12. Developing a Cancer Digital Twin: Supervised Metastases Detection From Consecutive Structured Radiology Reports

    Authors: , , , , , , , , , , , , - Frontiers in Artificial Intelligence, Frontiers Artif. Intell. 2022 cited by 62

  13. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control

    Authors: , , , , , , , , , , - Journal of Vascular and Interventional Radiology 2017 cited by 276

  14. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 377

  15. LI-RADS: Looking Back, Looking Forward

    Authors: , , , , , , , , , - Radiology 2023 cited by 68

  16. Margin Size is an Independent Predictor of Local Tumor Progression After Ablation of Colon Cancer Liver Metastases

    Authors: , , , , , , , , , , , , - CardioVascular and Interventional Radiology 2012 cited by 341

  17. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review

    Authors: , , , , , , , , , , , , , , , , , , , - Radiology 2017 cited by 321

  18. Computerized Diagnosis of Liver Tumors From CT Scans Using a Deep Neural Network Approach

    Authors: , , , , , , , , , , , , , , , - IEEE Journal of Biomedical and Health Informatics, IEEE J. Biomed. Health Informatics 2023 cited by 52

  19. Background, current role, and potential applications of radiogenomics

    Authors: , , , , , , , , - Journal of Magnetic Resonance Imaging 2017 cited by 182

  20. Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma

    Authors: , , , , , , , , , - Cancer Medicine 2021 cited by 45

  21. Influence of CT acquisition and reconstruction parameters on radiomic feature reproducibility

    Authors: , , , , - Journal of Medical Imaging 2018 cited by 113

  22. Patterns of Metastatic Disease in Patients with Cancer Derived from Natural Language Processing of Structured CT Radiology Reports over a 10-year Period

    Authors: , , , , , , , , , , , , , , , , , - Radiology 2021 cited by 53

  23. PD-1 Blockade in Advanced Adrenocortical Carcinoma

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 186

  24. Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of177Lu-DOTATATE in Neuroendocrine Tumors

    Authors: , , , , , , - Journal of Nuclear Medicine 2022 cited by 30